| 000 | 00991 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250514223621.0 | ||
| 264 | 0 | _c20050503 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(05)61022-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWierzbicki, Anthony S | |
| 245 | 0 | 0 |
_aCardiovascular risk assessment. _h[electronic resource] |
| 260 |
_bLancet (London, England) _c |
||
| 300 |
_a1305-6 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aCardiovascular Diseases _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypercholesterolemia _xcomplications |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aTwomey, Patrick J | |
| 700 | 1 | _aReynolds, Timothy M | |
| 773 | 0 |
_tLancet (London, England) _gvol. 365 _gno. 9467 _gp. 1305-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(05)61022-7 _zAvailable from publisher's website |
| 999 |
_c15492331 _d15492331 |
||